河北建新化工股份有限公司 董事会薪酬与考核委员会工作细则 河北建新化工股份有限公司 第三条 薪酬与考核委员会成员由三名董事组成，其中两名独立董事。 第四条 薪酬与考核委员会委员由董事长、二分之一以上独立董事或三分之一以 上董事提名，并由董事会选举产生。 选举委员的提案获得通过后，新任委员在董事会会议结束后立即就任。 第五条 薪酬与考核委员会设主任委员一名，由独立董事委员担任，负责主持委 员会工作；主任委员在委员内选举，并报请董事会批准产生。 第六条 薪酬与考核委员会任期与董事会任期一致，委员任期届满，连选可以连 任。期间如有委员不再担任公司董事职务，自动失去委员资格，并由董事会根据上 述第三条至第五条的规定补足委员人数。 董事会薪酬与考核委员会工作细则 第一章 总则 第一条 为进一步健全河北建新化工股份有限公司（以下简称"公司"）董事 （不含独立董事，下同）及高级管理人员的考核和薪酬管理制度，完善公司治理结 构，根据《中华人民共和国公司法》《上市公司治理准则》《上市公司独立董事管 理办法》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运 作》《河北建新化工股份有限公司章程》（以下简称"《公司 ...

Financial Performance - The company's revenue for Q3 2023 was ¥188,276,328.46, representing a 6.73% increase compared to the same period last year, but a 15.46% decrease year-to-date[5]. - Net profit attributable to shareholders for Q3 2023 was ¥2,394,461.14, down 82.10% year-on-year, and year-to-date net profit was ¥10,660,924.99, down 78.10%[5]. - Basic earnings per share for Q3 2023 was ¥0.0043, a decrease of 82.23% compared to the same period last year[5]. - Total operating revenue for the third quarter of 2023 was ¥468,864,747.78, a decrease of 15.4% compared to ¥554,603,019.37 in the same period last year[24]. - Net profit for the third quarter of 2023 was ¥10,660,924.99, a significant decline of 78.1% compared to ¥48,684,942.75 in the previous year[25]. - Total comprehensive income for the third quarter was CNY 10,660,924.99, a decrease from CNY 48,684,942.75 in the previous period[26]. - Basic earnings per share for the current period was CNY 0.0193, down from CNY 0.0882 in the previous period[26]. Assets and Liabilities - The total assets at the end of Q3 2023 were ¥1,627,391,821.02, a decrease of 2.38% from the end of the previous year[5]. - The company's total assets as of September 30, 2023, amounted to ¥1,627,391,821.02, a decrease from ¥1,667,031,573.76 at the beginning of the year[22]. - Current assets totaled ¥803,361,448.25, down 6.3% from ¥857,735,689.79 at the start of the year[21]. - Total current liabilities decreased to ¥137,518,475.00, down 23.9% from ¥180,631,652.19 year-over-year[22]. - The company's equity attributable to shareholders increased slightly to ¥1,461,296,090.28 from ¥1,460,586,134.15[22]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥19,975,348.81, down 83.07% compared to the same period last year[5]. - Net cash flow from operating activities was CNY 19,975,348.81, significantly lower than CNY 117,954,774.43 in the previous period[29]. - Cash inflow from operating activities totaled CNY 314,676,302.29, compared to CNY 417,335,683.50 in the previous period[28]. - Cash outflow from operating activities was CNY 294,700,953.48, slightly decreased from CNY 299,380,909.07 in the previous period[29]. - Net cash flow from investing activities was -CNY 72,605,796.17, an improvement from -CNY 136,580,025.59 in the previous period[29]. - Cash flow from financing activities resulted in a net outflow of -CNY 22,417,814.71, compared to -CNY 133,537,817.01 in the previous period[29]. - The ending balance of cash and cash equivalents was CNY 279,756,654.22, compared to CNY 244,406,730.47 in the previous period[29]. - The company reported a decrease in cash received from sales of goods and services, totaling CNY 291,562,150.20, down from CNY 384,202,030.26[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 24,358[11]. - The largest shareholder, Zhu Shouchan, holds 38.82% of the shares, totaling 215,768,643 shares[11]. - The total number of unrestricted shares held by the top 10 shareholders amounts to 53,942,161 shares for Zhu Shouchan[12]. - The company has a total of 214,985,635 restricted shares at the end of the reporting period[15]. - The top 10 shareholders include Zhu Zairui, Huang Jifen, and Chen Wufeng, with respective holdings of 6.47%, 3.59%, and 1.39%[11]. Stock Options and Incentives - The company plans to adjust the stock option exercise price and the grant price of restricted stock as per the board's resolutions[16]. - A total of 332.72 million stock options can be exercised by 74 incentive objects during the first exercise period from September 14, 2023, to July 10, 2024[18]. - The company completed the cancellation of 497,800 stock options that were granted but not exercised[17]. - The number of stock options granted has been adjusted from 7,258,000 to 6,760,200, accounting for 1.23% of the current total share capital[17]. - The company has 403.75 million restricted stocks that will be listed for trading on September 14, 2023[18]. Other Financial Metrics - The company experienced a 15.46% decline in total revenue year-to-date, primarily due to a decrease in sales prices of main products[8]. - Investment income for Q3 2023 decreased by 70.23% to ¥420,116.15, attributed to reduced returns from wealth management investments[9]. - The net cash flow from financing activities decreased by 83.21% year-to-date, mainly due to reduced guarantee margin expenditures and lower dividends[9]. - The company reported a significant increase in trading financial assets by 88.50% to ¥37,700,000.00 due to increased bank wealth management investments[8]. - Research and development expenses for the third quarter were ¥23,572,388.53, a decrease of 8.8% compared to ¥25,856,533.48 in the previous year[25]. Audit Status - The company has not undergone an audit for the third quarter report[31].

证券代码：300107 证券简称：建新股份 公告编号：2023-050 公司董事会将督促承诺人严格遵守承诺，并按照《中华人民共和国公司法》 《中华人民共和国证券法》以及证监会、深圳证券交易所相关法律法规的规定， 及时履行信息披露义务。 未来十二个月不减持公司股份的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）近日收到控股股东、实际 控制人朱守琛先生出具的《关于自愿不减持公司股份的承诺函》，现将相关情况 公告如下： 基于对公司未来发展前景的信心及公司价值的认可，为支持公司持续、稳定、 健康发展，增强广大投资者信心，公司控股股东、实际控制人朱守琛先生自愿承 诺，自承诺函签署之日起 12 个月内（2023 年 10 月 16 日至 2024 年 10 月 15 日） 不减持其所持有的公司股份；在上述承诺期间内，承诺主体因公司发生资本公积 转增股本、派送股票红利、配股、增发等事项取得的新增股份亦遵守上述承诺。 截至本公告披露日，控股股东、实际控制人朱守琛先生持有公司股份 215,768,643 股，占公司总股本比例为 ...

证券代码：300107 证券简称：建新股份 公告编号：2023-049 河北建新化工股份有限公司 关于 2022 年股票期权与限制性股票激励计划 之股票期权第一个行权期采用自主行权的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、公司 2022 年股票期权与限制性股票激励计划股票期权代码：036503，期 权简称：建新 JLC3。 2、本次符合行权条件的 74 名激励对象在第一个行权期可行权 332.72 万份 股票期权，行权价格为 5.39 元/份。 3、本次行权拟采用自主行权模式，实际可行权期限为 2023 年 9 月 14 日至 2024 年 7 月 10 日。 4、本次可行权期权若全部行权，公司股份仍具备上市条件。 河北建新化工股份有限公司（以下简称"公司"）于 2023 年 7 月 11 日召开 的第六届董事会第二次会议、第六届监事会第二次会议，审议通过了《关于 2022 年股票期权与限制性股票激励计划之股票期权第一个行权期行权条件成就的议 案》。根据 2022 年第一次临时股东大会的相关授权，公司董事会将按照相关规 定办 ...

证券代码：300107 证券简称：建新股份 公告编号：2023-048 河北建新化工股份有限公司 2022 年股票期权与限制性股票激励计划之限制性股票第一个归 属期归属结果暨股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、本次归属股票数量：403.75 万股，占归属前公司总股本的比例为 0.73%。 2、本次归属股票上市流通时间：2023 年 9 月 14 日。 4、授予数量（调整前）：公司向激励对象授予 819.50 万股限制性股票 3、本次限制性股票归属条件的激励对象共计 23 人。 4、本次限制性股票归属股票来源：公司向激励对象定向发行公司 A 股普通 股。 河北建新化工股份有限公司（以下简称"公司"）于 2023 年 7 月 11 日召开第 六届董事会第二次会议、第六届监事会第二次会议，审议通过了《关于 2022 年 股票期权与限制性股票激励计划之限制性股票第一个归属期归属条件成就的议 案》。近日，公司办理了 2022 年股票期权与限制性股票激励计划之限制性票第 一个归属期归属股份的登记工作，现将相关事项公 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥280,588,419.32, a decrease of 25.81% compared to ¥378,201,946.89 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥8,266,463.85, down 76.59% from ¥35,305,761.32 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥6,231,636.07, representing an 81.59% decrease from ¥33,849,539.65 in the same period last year[22]. - The net cash flow from operating activities was ¥17,752,153.65, a decline of 76.19% compared to ¥74,547,016.06 in the previous year[22]. - Basic earnings per share were ¥0.0150, down 76.56% from ¥0.0640 in the same period last year[22]. - The total profit for the period was 9.69 million yuan, down 75.69% year-on-year[34]. - The company reported a significant increase in trading financial assets to ¥30,540,000.00, up from ¥20,000,492.46, representing 1.89% of total assets[47]. - The total revenue for the first half of 2023 was 85 million RMB, representing a 67% increase compared to the same period last year[59]. - The net profit for the first half of 2023 reached 3 million RMB, with a significant increase of 140% year-on-year[59]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,614,877,774.07, a decrease of 3.13% from ¥1,667,011,929.77 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company were ¥1,444,789,443.52, down 1.08% from ¥1,460,586,134.15 at the end of the previous year[22]. - Cash and cash equivalents decreased to ¥440,926,031.43, accounting for 27.30% of total assets, down from 30.18%[47]. - Accounts receivable dropped to ¥70,357,505.75, representing 4.36% of total assets, down from 6.01%[47]. - Inventory increased to ¥149,012,253.28, now 9.23% of total assets, up from 6.89%[47]. - Fixed assets rose to ¥519,684,356.22, making up 32.18% of total assets, an increase from 29.92%[47]. - Total liabilities decreased to CNY 170,088,330.55 from CNY 206,445,439.61, a reduction of approximately 17.6%[138]. Business Operations - The main business includes the production and sales of benzene-based intermediates, with applications in pharmaceuticals, agrochemicals, dyes, and paper chemicals[30]. - The company has established long-term stable partnerships with global chemical giants, with products sold in over 20 countries and regions[33]. - The company is focusing on optimizing the industrial chain structure and aims to enhance product value through technological advancements[33]. - The company is implementing a strategy of "horizontal expansion and vertical elongation" to drive long-term growth[33]. - The company is leveraging new technologies such as industrial IoT to enhance operational efficiency and product quality[34]. - The company has a complete direct sales system and a stable sales and after-sales service team to ensure customer satisfaction[31]. - The company plans to expand its product offerings in the chemical sector, focusing on new technologies and market segments[51]. - The company is actively involved in the research and development of new products and technologies to enhance its market competitiveness[54]. Investment and Financial Strategy - The company did not engage in any fundraising activities during the reporting period, maintaining a conservative financial strategy[55]. - The company has not reported any significant non-equity investments during the reporting period, reflecting a cautious investment approach[56]. - The company is exploring potential mergers and acquisitions to expand its market presence and product offerings[54]. - The company plans to increase its investment in its wholly-owned subsidiary, Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd., by RMB 100 million, raising its registered capital from RMB 150 million to RMB 250 million[66]. - The company has made strategic investments in new projects, including a capital increase in a subsidiary focused on chemical production[51]. Environmental and Social Responsibility - The company has developed a complete set of wastewater treatment facilities that achieve 80% resource reuse of industrial wastewater, ensuring sustainable development[41]. - The company is committed to increasing its environmental protection investments to comply with stricter regulations in the fine chemical industry[70]. - The company has implemented a self-monitoring plan for environmental emissions, which includes monitoring various pollutants and their discharge limits[87]. - The company emphasizes social responsibility by integrating it into shareholder and employee rights protection, as well as environmental protection[89]. - The company actively participates in community development through public welfare initiatives, including water supply improvements and public lighting installations[91]. Risk Management - The management has highlighted risks related to macro policies and market conditions that may impact future performance[5]. - The company faces macro policy risks but believes its product development strategy aligns with national industrial policy, minimizing such risks[68]. - The company is exposed to market risks due to rising overseas energy prices and high inflation, which may adversely affect its export business[68]. - The company emphasizes the importance of attracting and retaining high-quality technical and management talent to mitigate risks associated with talent shortages[69]. - The company exports a significant portion of its products, making it vulnerable to exchange rate fluctuations, particularly against the US dollar[69]. Shareholder Information - The company did not distribute cash dividends or bonus shares for the half-year period[77]. - The company approved the stock option and restricted stock incentive plan on July 1, 2022, granting 7.258 million stock options to 78 incentive recipients and 8.195 million restricted shares to 23 recipients[79]. - The largest shareholder, Zhu Shouchan, holds 39.11% of the total shares, amounting to 215,768,643 shares, with 161,826,482 being restricted[124]. - The total number of shareholders at the end of the reporting period was 25,232[123]. - The company has a policy that limits the transfer of shares by directors and senior management to no more than 25% of their total holdings each year[118]. Compliance and Governance - The semi-annual financial report for 2023 has not been audited[97]. - The company has adhered to all commitments made regarding equity incentives and related party transactions[1][2]. - The company has not engaged in any asset or equity acquisitions or sales during the reporting period[100]. - The company has not reported any entrusted loans in the current reporting period[61]. - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[71].

证券代码：300107 证券简称：建新股份 公告编号：2023-043 董 事 会 二〇二三年八月十七日 第六届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）第六届董事会第三次会议 于2023年8月17日在公司会议室以现场结合通讯方式召开。会议通知于2023年8 月7日以书面及通讯的方式发出，本次会议应出席董事9人，实际出席董事9人， 会议由公司董事长朱守琛先生主持。公司全体监事、部分高级管理人员列席了会 议。会议的召集、召开、表决程序符合《中华人民共和国公司法》和《公司章程》 的规定。会议经全体董事表决，通过以下事项： 审议通过了《关于<2023年半年度报告>及其摘要的议案》 董事会认为，《2023年半年度报告》及其摘要的内容能够真实、准确、完整 地反映公司经营情况，不存在虚假记载、误导性陈述或重大遗漏。 公司《2023年半年度报告》及其摘要，详见同日披露于中国证监会指定的创 业板上市公司信息披露网站巨潮资讯网(www.cninfo.com.cn)的公告。 本议案以同意9票，反对0票，弃 ...

河北建新化工股份有限公司独立董事 关于第六届董事会第三次会议相关事项的独立意见 根据《关于在上市公司建立独立董事制度的指导意见》、《深圳证券交易所 创业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》、河北建新化工股份有限公司（以下简称"公司"）《独 立董事工作细则》和《公司章程》的有关规定，我们作为公司的独立董事，对公 司第六届董事会第三次会议相关事项进行了认真审议，并发表如下独立意见： 关于控股股东及其他关联方占用公司资金、公司对外担保情况的独立意见 根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要 求》（证监会公告〔2022〕26 号）、《深圳证券交易所创业板上市公司自律监 管指南第 1 号——业务办理》等相关文件规定,我们对 2023 年半年度公司控股股 东及关联方占用公司资金和对外担保情况进行了认真核查,发表独立意见如下: 李胜楠 张先中 张兰丁 （此页无正文，为《河北建新化工股份有限公司独立董事关于第六届董事 会第三次会议相关事项的独立意见》之签字页） 1、报告期内，公司不存在控股股东、实际控制人及其他关联方占用公司资 金的情况。 ...

公司《2023 年半年度报告》及其摘要，详见同日披露于中国证监会指定的 创业板上市公司信息披露网站巨潮资讯网(www.cninfo.com.cn)的公告。 证券代码：300107 证券简称：建新股份 公告编号：2023-044 河北建新化工股份有限公司 第六届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）第六届监事会第三次会议 于2023年8月17日在公司会议室以现场方式召开。会议通知于2023年8月7日以书 面及通讯的方式发出，本次会议应出席监事3人，实际出席监事3人，会议由公司 监事会主席孙维政先生主持。公司部分董事、高级管理人员列席了会议。会议召 集、召开、表决程序符合《中华人民共和国公司法》和《公司章程》的规定。会 议经全体监事表决，通过以下事项： 审议通过了《关于<2023 年半年度报告>及其摘要的议案》 经审核，监事会认为董事会编制和审核河北建新化工股份有限公司《2023 年半年度报告》及其摘要的程序符合法律、行政法规和中国证监会的规定，报告 内容真实、准确、完整的反映了上市公 ...

河北建新化工股份有限公司 | 非经营性资金占用 | | 资金占用 | 占用方与上市公司 | 上市公司核 | 2023 年初占用 | 2023 年半年度占用 累计发生金额（不 | 2023 年半年度 占用资金的利息 | 2023 年半年度 偿还累计发生 | 2023 年半年 末占用资金 | 占用形成原 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 方名称 | 的关联关系 | 算的会计科目 | 资金余额 | 含利息） | （如有） | 额 | 余额 | 因 | | | 控股股东、实际控制人及其 | | | | | | | | | | | 非经营性占用 | | 附属企业 | | | | | | | | | | | 非经营性占用 | | 小 | 计 | —— | —— | —— | | | | | | —— | —— | | 前控股股东、实际控制人及 | | | | | | | | | | | 非经营性占用 | | 其附属企业 | | | | | | | | | | | 非经营性占用 | ...